The attorneys at Montgomery & Ponder, LLC are beginning to investigate cases regarding the Zostavax, a vaccine made by Merck to prevent shingles. Since the vaccine was approved by the FDA in 2006, over 36 million Americans have been injected with Zostavax. Lawsuits have begun to be filed across the United States due to injuries such as loss of eyesight, complete and permanent hearing loss, stroke, and patients actually contracting shingles.
Beginning in 2017, the U.S. Center of Disease Control began recommending the vaccine Shingrix instead of Zostavax. Merck was earning up to $685 Million per year from sales of Zostavax alone in the years of 2006-2017. As of July 2018, nearly 60 federal lawsuits had been filed against Merck due to injuries related to the shingles vaccine. Thousands more lawsuits are expected to be filed related to this Zostavax.
A multi-district lawsuit has just been filed where the primary plaintiff claims to have suffered permanent tissue decay in his retina as a result of the vaccine. The lawsuit claims that “[i]f the plaintiffs were equipped with the knowledge of the defective conditions and potential harms of the Zostavax vaccine, they would not have purchased it and agreed to have it injected into their body.” The FDA has recently updated the vaccine’s warning label to include things like vision damage and eye inflammation, which were previously not included.
Common side effects of Zostavax include:
- Joint or muscle pain
- Skin rash
- Injection site reactions
Serious side effects could include:
- Hearing loss
- Vision problems including blindness, eye infections, and retinal damage
- Postherpetic neuralgia
- Heart failure
- Development of shingles
If you or a loved one has sustained an injury related to the Zostavax shingles vaccine, please contact the attorneys at Montgomery & Ponder, LLC immediately at (205) 377-5004.